{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T00:14:05Z","timestamp":1793924045241,"version":"4.8.0"},"reference-count":236,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["108 258"],"award-info":[{"award-number":["108 258"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["122 504"],"award-info":[{"award-number":["122 504"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Steroids"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.steroids.2024.109423","type":"journal-article","created":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T02:58:39Z","timestamp":1713236319000},"page":"109423","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Sex and sex steroids as determinants of cardiovascular risk"],"prefix":"10.1016","volume":"206","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4820-4876","authenticated-orcid":false,"given":"Andrea","family":"Cignarella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Bolego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8200-4341","authenticated-orcid":false,"given":"Matthias","family":"Barton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.steroids.2024.109423_b0005","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.cardiores.2005.03.003","article-title":"Aging and biomedicine 2005: where should we go from here?","volume":"66","author":"Barton","year":"2005","journal-title":"Cardiovasc. Res."},{"issue":"4","key":"10.1016\/j.steroids.2024.109423_b0010","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1161\/CIRCRESAHA.121.319891","article-title":"Genetic, molecular, and cellular determinants of sex-specific cardiovascular traits","volume":"130","author":"Vaura","year":"2022","journal-title":"Circ. Res."},{"issue":"24","key":"10.1016\/j.steroids.2024.109423_b0015","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1016\/j.jacc.2021.05.051","article-title":"Race and ethnicity considerations in patients with coronary artery disease and stroke: JACC Focus Seminar 3\/9","volume":"78","author":"Mital","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"issue":"25","key":"10.1016\/j.steroids.2024.109423_b0020","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"GBD-NHLBI-JACC Global Burden of Cardiovascular Diseases Writing Group. Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study","volume":"76","author":"Roth","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.steroids.2024.109423_b0025","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/13697137.2018.1547701","article-title":"The evolution of the human menopause","volume":"22","author":"Lumsden","year":"2019","journal-title":"Climacteric"},{"issue":"8","key":"10.1016\/j.steroids.2024.109423_b0030","doi-asserted-by":"crossref","first-page":"e1003731","DOI":"10.1371\/journal.pmed.1003731","article-title":"Menopausal hormone therapy and women's health: an umbrella review","volume":"18","author":"Zhang","year":"2021","journal-title":"PLoS Med."},{"issue":"24","key":"10.1016\/j.steroids.2024.109423_b0035","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1001\/jama.2019.19191","article-title":"Association of premature natural and surgical menopause with incident cardiovascular disease","volume":"322","author":"Honigberg","year":"2019","journal-title":"JAMA"},{"issue":"21","key":"10.1016\/j.steroids.2024.109423_b0040","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1136\/heartjnl-2018-314268","article-title":"Unique cardiovascular risk factors in women","volume":"105","author":"Young","year":"2019","journal-title":"Heart"},{"issue":"14","key":"10.1016\/j.steroids.2024.109423_b0045","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1161\/CIRCULATIONAHA.114.013797","article-title":"How does cardiovascular disease first present in women and men? Incidence of 12 cardiovascular diseases in a contemporary cohort of 1,937,360 people","volume":"132","author":"George","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.steroids.2024.109423_b0050","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g5992","article-title":"Sex differences in lifetime risk and first manifestation of cardiovascular disease: prospective population-based cohort study","volume":"349","author":"Leening","year":"2014","journal-title":"BMJ"},{"issue":"18","key":"10.1016\/j.steroids.2024.109423_b0055","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1001\/jama.2012.3490","article-title":"Sex differences in stroke risk among older patients with recently diagnosed atrial fibrillation","volume":"307","author":"Avgil Tsadok","year":"2012","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.steroids.2024.109423_b0060","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1161\/CIRCULATIONAHA.105.553438","article-title":"Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study","volume":"112","author":"Fang","year":"2005","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.steroids.2024.109423_b0065","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.jacc.2006.10.047","article-title":"Gender-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Heart Survey on Atrial Fibrillation","volume":"49","author":"Dagres","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.steroids.2024.109423_b0070","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/978-3-319-77932-4_27","article-title":"Sex-specific physiology and cardiovascular disease","volume":"1065","author":"Shufelt","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.steroids.2024.109423_b0075","article-title":"Sex differences in risk factors for myocardial infarction: cohort study of UK Biobank participants","volume":"363","author":"Millett","year":"2018","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.steroids.2024.109423_b0080","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1503\/cmaj.051455","article-title":"A comprehensive view of sex-specific issues related to cardiovascular disease","volume":"176","author":"Pilote","year":"2007","journal-title":"CMAJ"},{"issue":"11","key":"10.1016\/j.steroids.2024.109423_b0085","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1093\/cvr\/27.11.1939","article-title":"Endothelium independent relaxation of human coronary arteries by 17\u03b2-oestradiol in vitro","volume":"27","author":"M\u00fcgge","year":"1993","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.steroids.2024.109423_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2023.117276","article-title":"Sex differences in diagnostic modalities of coronary artery disease: evidence from coronary microcirculation","volume":"384","author":"Civieri","year":"2023","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.steroids.2024.109423_b0095","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.jcmg.2016.02.003","article-title":"Imaging microvascular dysfunction and mechanisms for female-male differences in CAD","volume":"9","author":"Patel","year":"2016","journal-title":"J. Am. Coll. Cardiol. Img."},{"issue":"6","key":"10.1016\/j.steroids.2024.109423_b0100","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.jacbts.2020.03.017","article-title":"Taking sex seriously: an oft-overlooked biological variable","volume":"5","author":"Libby","year":"2020","journal-title":"JACC Basic Transl Sci."},{"issue":"9","key":"10.1016\/j.steroids.2024.109423_b0105","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1161\/01.CIR.99.9.1165","article-title":"Sex, age, cardiovascular risk factors, and coronary heart disease: a prospective follow-up study of 14 786 middle-aged men and women in Finland","volume":"99","author":"Jousilahti","year":"1999","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.steroids.2024.109423_b0110","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1089\/jwh.2005.14.820","article-title":"Asia Pacific Cohort Studies Collaboration. Does sex matter in the associations between classic risk factors and fatal coronary heart disease in populations from the Asia-Pacific region?","volume":"14","author":"Huxley","year":"2005","journal-title":"J. Womens Health (Larchmt)"},{"issue":"1A","key":"10.1016\/j.steroids.2024.109423_b0115","doi-asserted-by":"crossref","first-page":"40S","DOI":"10.1016\/S0002-9343(99)80058-8","article-title":"Endogenous sex hormones: impact on lipids, lipoproteins, and insulin","volume":"98","author":"Haffner","year":"1995","journal-title":"Am. J. Med."},{"issue":"25","key":"10.1016\/j.steroids.2024.109423_b0120","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1016\/j.jacc.2009.10.009","article-title":"Are changes in cardiovascular disease risk factors in midlife women due to chronological aging or to the menopausal transition?","volume":"54","author":"Matthews","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"10.1016\/j.steroids.2024.109423_b0125","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41569-023-00926-7","article-title":"The menopausal transition period and cardiovascular risk","volume":"21","author":"Mehta","year":"2024","journal-title":"Nat. Rev. Cardiol."},{"issue":"9976","key":"10.1016\/j.steroids.2024.109423_b0130","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/S0140-6736(14)61368-4","article-title":"C Baigent, A Keech, Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials","volume":"385","author":"Cholesterol Treatment Trialists\u2019 (CTT) Collaboration","year":"2015","journal-title":"Lancet"},{"issue":"9753","key":"10.1016\/j.steroids.2024.109423_b0135","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials","volume":"376","author":"Cholesterol Treatment Trialists\u2019 (CTT) Collaboration","year":"2010","journal-title":"Lancet"},{"issue":"32","key":"10.1016\/j.steroids.2024.109423_b0140","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease \u2013 1. Evidence from genetic, epidemiologic, and clinical studies \u2013 a consensus statement from the European Atherosclerosis Society Consensus Panel","volume":"38","author":"Ference","year":"2017","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.steroids.2024.109423_b0145","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.atherosclerosis.2008.06.002","article-title":"Association between lipid profile and circulating concentrations of estrogens in young men","volume":"203","author":"Tomaszewski","year":"2009","journal-title":"Atherosclerosis"},{"issue":"23","key":"10.1016\/j.steroids.2024.109423_b0150","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1093\/eurheartj\/ehq386","article-title":"Lipoprotein(a) as a cardiovascular risk factor: current status","volume":"31","author":"Nordestgaard","year":"2010","journal-title":"Eur. Heart J."},{"issue":"39","key":"10.1016\/j.steroids.2024.109423_b0155","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1093\/eurheartj\/ehac361","article-title":"Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement","volume":"43","author":"Kronenberg","year":"2022","journal-title":"Eur. Heart J."},{"issue":"22","key":"10.1016\/j.steroids.2024.109423_b0160","doi-asserted-by":"crossref","first-page":"15569","DOI":"10.1074\/jbc.274.22.15569","article-title":"Estrogen modulation of apolipoprotein(a) expression \u2013 identification of a regulatory element","volume":"274","author":"Boffelli","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.steroids.2024.109423_b0165","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.atherosclerosis.2022.04.006","article-title":"Non-genetic influences on lipoprotein(a) concentrations","volume":"349","author":"Enkhmaa","year":"2022","journal-title":"Atherosclerosis"},{"issue":"10","key":"10.1016\/j.steroids.2024.109423_b0170","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1161\/01.CIR.97.10.979","article-title":"and for the PEPI Investigators. Effect of postmenopausal hormone therapy on lipoprotein(a) concentration","volume":"97","author":"Espeland","year":"1998","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.steroids.2024.109423_b0175","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1113\/JP279501","article-title":"The role of oestrogen in determining sexual dimorphism in energy balance","volume":"601","author":"De Jesus","year":"2023","journal-title":"J. Physiol."},{"key":"10.1016\/j.steroids.2024.109423_b0180","doi-asserted-by":"crossref","first-page":"e984","DOI":"10.1161\/CIR.0000000000000973","article-title":"Obesity and Cardiovascular Disease: a Scientific Statement from the American Heart Association","volume":"143","author":"Powell-Wiley","year":"2021","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.steroids.2024.109423_b0185","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1001\/jama.2015.7008","article-title":"Association of cardiometabolic multimorbidity with mortality","volume":"314","author":"Di Angelantonio","year":"2015","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.steroids.2024.109423_b0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00125-012-2694-y","article-title":"Type 2 diabetes and cardiovascular disease in women","volume":"56","author":"Norhammar","year":"2013","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.steroids.2024.109423_b0195","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0002-8703(00)90043-7","article-title":"Sex differences in coronary artery size assessed by intravascular ultrasound","volume":"139","author":"Sheifer","year":"2000","journal-title":"Am. Heart J."},{"issue":"1","key":"10.1016\/j.steroids.2024.109423_b0200","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1748-1716.2010.02237.x","article-title":"Obesity, insulin resistance and diabetes: sex differences and role of oestrogen receptors","volume":"203","author":"Meyer","year":"2011","journal-title":"Acta Physiol (Oxf.)"},{"key":"10.1016\/j.steroids.2024.109423_b0205","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.tips.2010.01.001","article-title":"Emerging role of estrogen in the control of cardiometabolic disease","volume":"31","author":"Cignarella","year":"2010","journal-title":"Trends Pharmacol. Sci."},{"issue":"3","key":"10.1016\/j.steroids.2024.109423_b0210","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3109\/13697130903296909","article-title":"Obesity, metabolic complications and the menopause: an opportunity for prevention","volume":"13","author":"Teede","year":"2010","journal-title":"Climacteric"},{"key":"10.1016\/j.steroids.2024.109423_b0215","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/978-3-319-70178-3_11","article-title":"Menopause, estrogens, and glucose homeostasis in women","volume":"1043","author":"Mauvais-Jarvis","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"issue":"25","key":"10.1016\/j.steroids.2024.109423_b0220","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1016\/j.jacc.2022.11.005","article-title":"The global burden of cardiovascular diseases and risk","volume":"80","author":"Vaduganathan","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"issue":"6","key":"10.1016\/j.steroids.2024.109423_b0225","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1161\/HYPERTENSIONAHA.122.20448","article-title":"Arterial hypertension in women: State of the Art and knowledge gaps","volume":"80","author":"Chapman","year":"2023","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.steroids.2024.109423_b0230","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1161\/HYPERTENSIONAHA.108.120022","article-title":"Postmenopausal hypertension: mechanisms and therapy","volume":"54","author":"Barton","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.steroids.2024.109423_b0235","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S0008-6363(01)00527-2","article-title":"Sex hormones and hypertension","volume":"53","author":"Dubey","year":"2002","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.steroids.2024.109423_b0240","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1161\/01.HYP.0000223064.62762.0b","article-title":"Gender differences of cardiovascular disease: new perspectives for estrogen receptor signaling","volume":"47","author":"Meyer","year":"2006","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.steroids.2024.109423_b0245","first-page":"H592","article-title":"ETB receptor-mediated vasodilation is regulated by estradiol in young women","volume":"321","author":"Shoemaker","year":"2021","journal-title":"Am. J. Phys. Heart Circ. Phys."},{"issue":"13","key":"10.1016\/j.steroids.2024.109423_b0250","doi-asserted-by":"crossref","first-page":"e008950","DOI":"10.1161\/JAHA.118.008950","article-title":"Predominant role of nuclear versus membrane estrogen receptor \u03b1 in arterial protection: implications for estrogen receptor \u03b1 modulation in cardiovascular prevention\/safety","volume":"7","author":"Guivarc'h","year":"2018","journal-title":"J. Am. Heart Assoc."},{"issue":"4","key":"10.1016\/j.steroids.2024.109423_b0255","first-page":"H1770","article-title":"Estrogen receptor-\u03b1 mediates estrogen protection from angiotensin II-induced hypertension in conscious female mice","volume":"292","author":"Xue","year":"2007","journal-title":"Am. J. Phys. Heart Circ. Phys."},{"key":"10.1016\/j.steroids.2024.109423_b0260","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13293-016-0111-9","article-title":"Impact of gonadectomy on blood pressure regulation in ageing male and female rats","volume":"7","author":"Pijacka","year":"2016","journal-title":"Biol. Sex Differ."},{"issue":"8","key":"10.1016\/j.steroids.2024.109423_b0265","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1161\/CIRCRESAHA.111.246876","article-title":"The intersection between aging and cardiovascular disease","volume":"110","author":"North","year":"2012","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.steroids.2024.109423_b0270","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12916-016-0762-8","article-title":"Unraveling the associations of age and menopause with cardiovascular risk factors in a large population-based study","volume":"15","author":"de Kat","year":"2017","journal-title":"BMC Med."},{"issue":"1","key":"10.1016\/j.steroids.2024.109423_b0275","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1210\/en.2008-0640","article-title":"Role of aging versus the loss of estrogens in the reduction in vascular function in female rats","volume":"150","author":"Stice","year":"2009","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.steroids.2024.109423_b0280","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1161\/HYPERTENSIONAHA.107.106807","article-title":"Prolonged ovarian hormone deprivation impairs the protective vascular actions of estrogen receptor \u03b1 agonists","volume":"51","author":"Pinna","year":"2008","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.steroids.2024.109423_b0285","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1007\/s11357-020-00236-7","article-title":"Decline in endothelial function across the menopause transition in healthy women is related to decreased estradiol and increased oxidative stress","volume":"42","author":"Moreau","year":"2020","journal-title":"Geroscience"},{"issue":"5","key":"10.1016\/j.steroids.2024.109423_b0290","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.fertnstert.2018.07.1152","article-title":"Cardiovascular health and ovarian aging","volume":"110","author":"Quinn","year":"2018","journal-title":"Fertil. Steril."},{"issue":"4","key":"10.1016\/j.steroids.2024.109423_b0295","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/nrendo.2017.180","article-title":"Symptoms of menopause - global prevalence, physiology and implications","volume":"14","author":"Monteleone","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"issue":"3","key":"10.1016\/j.steroids.2024.109423_b0300","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.molmed.2012.12.007","article-title":"Estrogen synthesis and signaling pathways during aging: from periphery to brain","volume":"19","author":"Cui","year":"2013","journal-title":"Trends Mol. Med."},{"issue":"25","key":"10.1016\/j.steroids.2024.109423_b0305","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1161\/CIRCULATIONAHA.109.898445","article-title":"Endothelial estrogen receptor-\u03b1 plays a crucial role in the atheroprotective action of 17\u03b2-estradiol in low-density lipoprotein receptor-deficient mice","volume":"120","author":"Billon-Gal\u00e9s","year":"2009","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.steroids.2024.109423_b0310","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1161\/ATVBAHA.109.192849","article-title":"Estrogen receptor \u03b1 expression in both endothelium and hematopoietic cells is required for the accelerative effect of estradiol on reendothelialization","volume":"29","author":"Toutain","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.steroids.2024.109423_b0315","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/bs.apha.2016.05.003","article-title":"Estrogens and coronary artery disease: new clinical perspectives","volume":"77","author":"Meyer","year":"2016","journal-title":"Adv. Pharmacol."},{"issue":"1","key":"10.1016\/j.steroids.2024.109423_b0320","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/FJC.0b013e31829709d4","article-title":"Alike but not the same: anatomic heterogeneity of estrogen receptor-mediated vasodilation","volume":"62","author":"Barton","year":"2013","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"7","key":"10.1016\/j.steroids.2024.109423_b0325","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/s41574-023-00822-7","article-title":"The G protein-coupled oestrogen receptor GPER in health and disease: an update","volume":"19","author":"Prossnitz","year":"2023","journal-title":"Nat. Rev. Endocrinol."},{"issue":"10","key":"10.1016\/j.steroids.2024.109423_b0330","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1093\/eurjpc\/zwac060","article-title":"Menopause modulates the circulating metabolome: evidence from a prospective cohort study","volume":"29","author":"Karppinen","year":"2022","journal-title":"Eur. J. Prev. Cardiol."},{"issue":"2","key":"10.1016\/j.steroids.2024.109423_b0335","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1161\/ATVBAHA.114.304821","article-title":"Extreme concentrations of endogenous sex hormones, ischemic heart disease, and death in women","volume":"35","author":"Benn","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"6","key":"10.1016\/j.steroids.2024.109423_b0340","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/GME.0000000000001568","article-title":"MAP.3 Investigators. Baseline estrogen levels in postmenopausal women participating in the MAP.3 breast cancer chemoprevention trial","volume":"27","author":"Richardson","year":"2020","journal-title":"Menopause"},{"issue":"12","key":"10.1016\/j.steroids.2024.109423_b0345","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/nrg2415","article-title":"Sex-specific genetic architecture of human disease","volume":"9","author":"Ober","year":"2008","journal-title":"Nat. Rev. Genet."},{"issue":"6","key":"10.1016\/j.steroids.2024.109423_b0350","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/0002-9378(88)90189-5","article-title":"Cardiovascular disease in women","volume":"158","author":"Castelli","year":"1988","journal-title":"Am J Obst Gynecol"},{"key":"10.1016\/j.steroids.2024.109423_b0355","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1517\/14656566.8.3.279","article-title":"Cardiovascular risk in women: the impact of hormone replacement therapy and prospects for new therapeutic approaches","volume":"8","author":"Jeanes","year":"2007","journal-title":"Expert Opin. Pharmacother."},{"issue":"2","key":"10.1016\/j.steroids.2024.109423_b0360","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.maturitas.2005.04.009","article-title":"The association between early menopause and risk of ischaemic heart disease: influence of hormone therapy","volume":"53","author":"L\u00f8kkegaard","year":"2006","journal-title":"Maturitas"},{"issue":"3","key":"10.1016\/j.steroids.2024.109423_b0365","first-page":"187","article-title":"Coronary heart disease: a substantial threat to women","volume":"86","author":"Wenger","year":"1997","journal-title":"J. Med. Assoc. Ga."},{"issue":"Suppl 1","key":"10.1016\/j.steroids.2024.109423_b0370","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1080\/13697130903013452","article-title":"Premature menopause increases cardiovascular risk","volume":"12","author":"Archer","year":"2009","journal-title":"Climacteric"},{"issue":"2","key":"10.1016\/j.steroids.2024.109423_b0375","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.coph.2013.01.005","article-title":"Menopause, atherosclerosis, and coronary artery disease","volume":"13","author":"Barrett-Connor","year":"2013","journal-title":"Curr. Opin. Pharmacol."},{"issue":"5","key":"10.1016\/j.steroids.2024.109423_b0380","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1097\/gme.0b013e31816b4509","article-title":"Lipid profile of women with premature ovarian failure","volume":"15","author":"Knauff","year":"2008","journal-title":"Menopause"},{"issue":"4","key":"10.1016\/j.steroids.2024.109423_b0385","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/humupd\/dms013","article-title":"Testosterone concentrations, using different assays, in different types of ovarian insufficiency: a systematic review and meta-analysis","volume":"18","author":"Janse","year":"2012","journal-title":"Hum. Reprod. Update"},{"issue":"10","key":"10.1016\/j.steroids.2024.109423_b0390","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1093\/humrep\/dev195","article-title":"Androgen levels in women with various forms of ovarian dysfunction: associations with cardiometabolic features","volume":"30","author":"Daan","year":"2015","journal-title":"Hum. Reprod."},{"issue":"1","key":"10.1016\/j.steroids.2024.109423_b0395","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/00042192-200101000-00008","article-title":"Influence of endogenous androgens on carotid wall in postmenopausal women","volume":"8","author":"Bernini","year":"2001","journal-title":"Menopause"},{"issue":"1","key":"10.1016\/j.steroids.2024.109423_b0400","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.atherosclerosis.2008.08.037","article-title":"Sex hormone levels and subclinical atherosclerosis in postmenopausal women: the Multi-Ethnic Study of Atherosclerosis","volume":"204","author":"Ouyang","year":"2009","journal-title":"Atherosclerosis"},{"issue":"12","key":"10.1016\/j.steroids.2024.109423_b0405","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1016\/j.cjca.2022.09.018","article-title":"Androgens and androgen receptors as determinants of vascular sex differences across the lifespan","volume":"38","author":"Lucas-Herald","year":"2022","journal-title":"Can. J. Cardiol."},{"issue":"2","key":"10.1016\/j.steroids.2024.109423_b0410","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1210\/jc.2009-1693","article-title":"Extremes of endogenous testosterone are associated with increased risk of incident coronary events in older women","volume":"95","author":"Laughlin","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10","key":"10.1016\/j.steroids.2024.109423_b0415","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/j.jacc.2005.01.052","article-title":"Increased carotid atherosclerosis in andropausal middle-aged men","volume":"45","author":"M\u00e4kinen","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"issue":"7256","key":"10.1016\/j.steroids.2024.109423_b0420","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1136\/bmj.321.7256.273","article-title":"Association of polymorphism of human \u03b1 oestrogen receptor gene with coronary artery disease in men: a necropsy study","volume":"321","author":"Kunnas","year":"2000","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.steroids.2024.109423_b0425","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s00109-001-0311-5","article-title":"Coronary artery wall atherosclerosis in relation to the estrogen receptor 1 gene polymorphism: an autopsy study","volume":"80","author":"Lehtim\u00e4ki","year":"2002","journal-title":"J Mol Med (Berlin)"},{"issue":"17","key":"10.1016\/j.steroids.2024.109423_b0430","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1001\/jama.290.17.2263","article-title":"Association between estrogen receptor \u03b1 gene variation and cardiovascular disease","volume":"290","author":"Shearman","year":"2003","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.steroids.2024.109423_b0435","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1096\/fj.08-119388","article-title":"Sex of the cell dictates its response: differential gene expression and sensitivity to cell death inducing stress in male and female cells","volume":"23","author":"Penaloza","year":"2009","journal-title":"FASEB J."},{"issue":"6","key":"10.1016\/j.steroids.2024.109423_b0440","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0168-9525(88)90020-0","article-title":"Sex determination in mammals","volume":"4","author":"McLaren","year":"1988","journal-title":"Trends Genet."},{"issue":"9","key":"10.1016\/j.steroids.2024.109423_b0445","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1101\/gr.275677.121","article-title":"Inferring genes that escape X-Chromosome inactivation reveals important contribution of variable escape genes to sex-biased diseases","volume":"31","author":"Sauteraud","year":"2021","journal-title":"Genome Res."},{"issue":"1","key":"10.1016\/j.steroids.2024.109423_b0450","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1038\/s41467-019-10462-z","article-title":"XX sex chromosome complement promotes atherosclerosis in mice","volume":"10","author":"AlSiraj","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.steroids.2024.109423_b0455","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1161\/ATVBAHA.116.307301","article-title":"Sex hormones and sex chromosomes cause sex differences in the development of cardiovascular diseases","volume":"37","author":"Arnold","year":"2017","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"10","key":"10.1016\/j.steroids.2024.109423_b0460","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1042\/CS20090077","article-title":"Effects of androgens on endothelial progenitor cells in vitro and in vivo","volume":"117","author":"Fadini","year":"2009","journal-title":"Clin. Sci. (Lond.)"},{"issue":"6","key":"10.1016\/j.steroids.2024.109423_b0465","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/molehr\/gaq015","article-title":"Endothelial progenitor cells as a new cardiovascular risk factor in Klinefelter's syndrome","volume":"16","author":"Di Mambro","year":"2010","journal-title":"Mol. Hum. Reprod."},{"issue":"5","key":"10.1016\/j.steroids.2024.109423_b0470","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1093\/humupd\/dmz017","article-title":"Transgenerational inheritance: how impacts to the epigenetic and genetic information of parents affect offspring health","volume":"25","author":"Xavier","year":"2019","journal-title":"Hum. Reprod. Update"},{"issue":"1","key":"10.1016\/j.steroids.2024.109423_b0475","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3109\/01485019808988547","article-title":"Germ cell apoptosis and endothelial nitric oxide synthase (eNOS) expression following ischemia-reperfusion injury to testis","volume":"41","author":"Zini","year":"1998","journal-title":"Arch. Androl."},{"issue":"7","key":"10.1016\/j.steroids.2024.109423_b0480","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1007\/s00125-022-05700-x","article-title":"Paternal eNOS deficiency in mice affects glucose homeostasis and liver glycogen in male offspring without inheritance of eNOS deficiency itself","volume":"65","author":"Hocher","year":"2022","journal-title":"Diabetologia"},{"issue":"7","key":"10.1016\/j.steroids.2024.109423_b0485","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1080\/15592294.2016.1184800","article-title":"Maternal eNOS deficiency determines a fatty liver phenotype of the offspring in a sex dependent manner","volume":"11","author":"Hocher","year":"2016","journal-title":"Epigenetics"},{"issue":"1","key":"10.1016\/j.steroids.2024.109423_b0490","doi-asserted-by":"crossref","first-page":"C296","DOI":"10.1152\/ajpcell.00537.2001","article-title":"Role of nitric oxide synthase isoforms in glucose-stimulated insulin release","volume":"283","author":"Henningsson","year":"2002","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"10","key":"10.1016\/j.steroids.2024.109423_b0495","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.2337\/db18-0288","article-title":"Acute nitric oxide synthase inhibition accelerates transendothelial insulin efflux in vivo","volume":"67","author":"Williams","year":"2018","journal-title":"Diabetes"},{"key":"10.1016\/j.steroids.2024.109423_b0500","doi-asserted-by":"crossref","DOI":"10.1056\/NEJM200007133430207","article-title":"The immune system","volume":"343","author":"Delves","year":"2000","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.steroids.2024.109423_b0505","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1161\/CIRCRESAHA.121.318052","article-title":"Hypertension: do inflammation and immunity hold the key to solving this epidemic?","volume":"128","author":"Madhur","year":"2021","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.steroids.2024.109423_b0510","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1161\/HYPERTENSIONAHA.110.163576","article-title":"Inflammation, immunity, and hypertension","volume":"57","author":"Harrison","year":"2011","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.steroids.2024.109423_b0515","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1161\/HYPERTENSIONAHA.116.07237","article-title":"Activation of human T cells in hypertension: studies of humanized mice and hypertensive humans","volume":"68","author":"Itani","year":"2016","journal-title":"Hypertension"},{"key":"10.1016\/j.steroids.2024.109423_b0520","doi-asserted-by":"crossref","DOI":"10.1016\/j.steroids.2023.109327","article-title":"Expression of functional mineralocorticoid receptor (MR) and G-protein coupled estrogen receptor (GPER) in human T lymphocytes","volume":"200","author":"Piazza","year":"2023","journal-title":"Steroids"},{"issue":"6","key":"10.1016\/j.steroids.2024.109423_b0525","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1161\/HYPERTENSIONAHA.122.20836","article-title":"Ovariectomy via 12\/15-lipoxygenase augments angiotensin II-induced hypertension and its pathogenesis in female mice","volume":"80","author":"Dutta","year":"2023","journal-title":"Hypertension"},{"issue":"15","key":"10.1016\/j.steroids.2024.109423_b0530","doi-asserted-by":"crossref","first-page":"12454","DOI":"10.1074\/jbc.M011361200","article-title":"Hydroxyeicosanoids bind to and activate the low affinity leukotriene B4 receptor, BLT2","volume":"276","author":"Yokomizo","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"13","key":"10.1016\/j.steroids.2024.109423_b0535","first-page":"2525","article-title":"Inflammation during the life cycle of the atherosclerotic plaque","volume":"117","author":"Libby","year":"2021","journal-title":"Cardiovasc. Res."},{"issue":"1","key":"10.1016\/j.steroids.2024.109423_b0540","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/clinchem\/hvaa275","article-title":"Inflammation in atherosclerosis-no longer a theory","volume":"67","author":"Libby","year":"2021","journal-title":"Clin. Chem."},{"issue":"17","key":"10.1016\/j.steroids.2024.109423_b0545","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1016\/j.jacc.2018.08.1043","article-title":"Inflammation, immunity, and infection in atherothrombosis: JACC review topic of the week","volume":"72","author":"Libby","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.steroids.2024.109423_b0550","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1161\/CIRCRESAHA.116.301313","article-title":"Inflammation and immunity in diseases of the arterial tree: players and layers","volume":"116","author":"Libby","year":"2015","journal-title":"Circ. Res."},{"issue":"9","key":"10.1016\/j.steroids.2024.109423_b0555","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1161\/ATVBAHA.108.179705","article-title":"Inflammation in atherosclerosis","volume":"32","author":"Libby","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"8","key":"10.1016\/j.steroids.2024.109423_b0560","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1161\/ATVBAHA.114.303887","article-title":"Oxidized low-density lipoprotein induces long-term proinflammatory cytokine production and foam cell formation via epigenetic reprogramming of monocytes","volume":"34","author":"Bekkering","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.steroids.2024.109423_b0565","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.freeradbiomed.2019.03.036","article-title":"An update on lipid oxidation and inflammation in cardiovascular diseases","volume":"144","author":"Zhong","year":"2019","journal-title":"Free Radic. Biol. Med."},{"issue":"2","key":"10.1016\/j.steroids.2024.109423_b0570","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/JLB.3AB1220-846R","article-title":"Immune modulatory effects of progesterone on oxLDL-induced trained immunity in monocytes","volume":"112","author":"Groh","year":"2022","journal-title":"J. Leukoc. Biol."},{"issue":"17","key":"10.1016\/j.steroids.2024.109423_b0575","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1161\/01.CIR.99.17.2317","article-title":"Androgen exposure increases human monocyte adhesion to vascular endothelium and endothelial cell expression of vascular cell adhesion molecule-1","volume":"99","author":"McCrohon","year":"1999","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.steroids.2024.109423_b0580","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0002-9378(97)70462-9","article-title":"17\u03b2-Estradiol, progesterone, and testosterone inversely modulate low-density lipoprotein oxidation and cytotoxicity in cultured placental trophoblast and macrophages","volume":"177","author":"Zhu","year":"1997","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.steroids.2024.109423_b0585","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/apha.12646","article-title":"Endothelial dysfunction and vascular disease - a 30th anniversary update","volume":"219","author":"Vanhoutte","year":"2017","journal-title":"Acta Physiol (Oxf.)"},{"key":"10.1016\/j.steroids.2024.109423_b0590","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.phrs.2017.01.011","article-title":"Endothelial maintenance in health and disease: importance of sex differences","volume":"119","author":"Mudrovcic","year":"2017","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.steroids.2024.109423_b0595","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2023.117278","article-title":"Sex differences in vascular endothelial cells","volume":"384","author":"Robert","year":"2023","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.steroids.2024.109423_b0600","doi-asserted-by":"crossref","first-page":"e00541","DOI":"10.1002\/prp2.541","article-title":"Individualized medicine: sex, hormones, genetics, and adverse drug reactions","volume":"7","author":"Moyer","year":"2019","journal-title":"Pharmacol. Res. Perspect."},{"issue":"12","key":"10.1016\/j.steroids.2024.109423_b0605","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1161\/CIRCRESAHA.122.320259","article-title":"Illuminating the mechanisms underlying sex differences in cardiovascular disease","volume":"130","author":"Reue","year":"2022","journal-title":"Circ. Res."},{"issue":"5","key":"10.1016\/j.steroids.2024.109423_b0610","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1161\/ATVBAHA.107.159558","article-title":"Gender differences in endothelial progenitor cells and cardiovascular risk profile: the role of female estrogens","volume":"28","author":"Fadini","year":"2008","journal-title":"Arterioscl Thromb Vasc Biol."},{"issue":"3","key":"10.1016\/j.steroids.2024.109423_b0615","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nri.2017.145","article-title":"Improving immune-vascular crosstalk for cancer immunotherapy","volume":"18","author":"Huang","year":"2018","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.steroids.2024.109423_b0620","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00109-018-1729-3","article-title":"Approaches to therapeutic angiogenesis for ischemic heart disease","volume":"97","author":"Johnson","year":"2019","journal-title":"J. Mol. Med. (Berlin)"},{"issue":"4","key":"10.1016\/j.steroids.2024.109423_b0625","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1124\/pr.56.4.3","article-title":"Vascular endothelial growth factor and angiogenesis","volume":"56","author":"Hoeben","year":"2004","journal-title":"Pharmacol. Rev."},{"issue":"10","key":"10.1016\/j.steroids.2024.109423_b0630","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nrm.2016.87","article-title":"Mechanisms and regulation of endothelial VEGF receptor signalling","volume":"17","author":"Simons","year":"2016","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"47","key":"10.1016\/j.steroids.2024.109423_b0635","doi-asserted-by":"crossref","first-page":"28316","DOI":"10.1074\/jbc.270.47.28316","article-title":"Possible participation of autocrine and paracrine vascular endothelial growth factors in hypoxia-induced proliferation of endothelial cells and pericytes","volume":"270","author":"Nomura","year":"1995","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.steroids.2024.109423_b0640","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/MCA.0000000000000104","article-title":"Single nucleotide polymorphisms associated with abnormal coronary microvascular function","volume":"25","author":"Yoshino","year":"2014","journal-title":"Coron. Artery Dis."},{"key":"10.1016\/j.steroids.2024.109423_b0645","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.587221","article-title":"Sex differences in the pro-angiogenic response of human endothelial cells: focus on PFKFB3 and FAK activation","volume":"11","author":"Boscaro","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.steroids.2024.109423_b0650","first-page":"945","article-title":"PFKFB3 is involved in breast cancer proliferation, migration, invasion and angiogenesis","volume":"52","author":"Peng","year":"2018","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.steroids.2024.109423_b0655","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cmet.2013.11.008","article-title":"Partial and transient reduction of glycolysis by PFKFB3 blockade reduces pathological angiogenesis","volume":"19","author":"Schoors","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.steroids.2024.109423_b0660","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1124\/jpet.116.238212","article-title":"The glycolytic enzyme PFKFB3 is involved in estrogen-mediated angiogenesis via GPER1","volume":"361","author":"Trenti","year":"2017","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.steroids.2024.109423_b0665","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1161\/ATVBAHA.113.303041","article-title":"Endothelial PFKFB3 plays a critical role in angiogenesis","volume":"34","author":"Xu","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.steroids.2024.109423_b0670","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1161\/CIRCULATIONAHA.113.001533","article-title":"Androgen receptor promotes sex-independent angiogenesis in response to ischemia and is required for activation of vascular endothelial growth factor receptor signaling","volume":"128","author":"Yoshida","year":"2013","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.steroids.2024.109423_b0675","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/MOL.0b013e3283613a94","article-title":"Cholesterol and atherosclerosis: modulation by oestrogen","volume":"24","author":"Barton","year":"2013","journal-title":"Curr. Opin. Lipidol."},{"issue":"6","key":"10.1016\/j.steroids.2024.109423_b0680","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/iub.48","article-title":"Estrogen is a modulator of vascular inflammation","volume":"60","author":"Chakrabarti","year":"2008","journal-title":"IUBMB Life"},{"issue":"5","key":"10.1016\/j.steroids.2024.109423_b0685","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1096\/fasebj.10.5.8621060","article-title":"The vascular protective effects of estrogen","volume":"10","author":"Farhat","year":"1996","journal-title":"FASEB J."},{"key":"10.1016\/j.steroids.2024.109423_b0690","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1161\/hs0202.102732","article-title":"17\u03b2-estradiol increases rat cerebrovascular prostacyclin synthesis by elevating cyclooxygenase-1 and prostacyclin synthase","volume":"33","author":"Ospina","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/j.steroids.2024.109423_b0695","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1126\/science.1103333","article-title":"COX-2-derived prostacyclin confers atheroprotection on female mice","volume":"306","author":"Egan","year":"2004","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.steroids.2024.109423_b0700","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1172\/JCI11320","article-title":"Estrogen receptor \u03b1 is a major mediator of 17\u03b2-estradiol\u2019s atheroprotective effects on lesion size in Apoe\u2013\/\u2013 mice","volume":"107","author":"Hodgin","year":"2001","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.steroids.2024.109423_b0705","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1172\/JCI0214066","article-title":"Interactions between endothelial nitric oxide synthase and sex hormones in vascular protection in mice","volume":"109","author":"Hodgin","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.steroids.2024.109423_b0710","doi-asserted-by":"crossref","first-page":"e157","DOI":"10.1371\/journal.pmed.0040157","article-title":"Traditional nonsteroidal anti-inflammatory drugs and postmenopausal hormone therapy: a drug-drug interaction?","volume":"4","author":"Garcia Rodriguez","year":"2007","journal-title":"PLoS Med."},{"issue":"1","key":"10.1016\/j.steroids.2024.109423_b0715","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1161\/01.HYP.33.1.170","article-title":"Hormones and vasoprotection","volume":"33","author":"Oparil","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.steroids.2024.109423_b0720","doi-asserted-by":"crossref","first-page":"e68695","DOI":"10.7554\/eLife.68695","article-title":"Membrane estrogen receptor alpha (ER\u03b1) participates in flow-mediated dilation in a ligand-independent manner","volume":"10","author":"Favre","year":"2021","journal-title":"eLife"},{"issue":"12","key":"10.1016\/j.steroids.2024.109423_b0725","doi-asserted-by":"crossref","first-page":"4495","DOI":"10.1210\/en.2002-220844","article-title":"Minireview: estrogen and mouse models of atherosclerosis","volume":"143","author":"Hodgin","year":"2002","journal-title":"Endocrinology"},{"issue":"5","key":"10.1016\/j.steroids.2024.109423_b0730","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1113\/expphysiol.2007.041806","article-title":"Tissue-specific regulation of ACE\/ACE2 and AT1\/AT2 receptor gene expression by oestrogen in apolipoprotein E\/oestrogen receptor-\u03b1 knock-out mice","volume":"93","author":"Brosnihan","year":"2008","journal-title":"Exp. Physiol."},{"issue":"3","key":"10.1016\/j.steroids.2024.109423_b0735","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1161\/CIRCRESAHA.108.190892","article-title":"Regulatory role of G protein-coupled estrogen receptor for vascular function and obesity","volume":"104","author":"Haas","year":"2009","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.steroids.2024.109423_b0740","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1161\/HYPERTENSIONAHA.111.184606","article-title":"Deletion of G protein-coupled estrogen receptor increases endothelial vasoconstriction","volume":"59","author":"Meyer","year":"2012","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.steroids.2024.109423_b0745","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/01.fjc.0000187174.67661.67","article-title":"Endothelium-dependent contractions occur in the aorta of wild-type and COX2-\/- knockout but not COX1-\/- knockout mice","volume":"46","author":"Tang","year":"2005","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"11","key":"10.1016\/j.steroids.2024.109423_b0750","doi-asserted-by":"crossref","first-page":"e79245","DOI":"10.1371\/journal.pone.0079245","article-title":"Regulation of vascular smooth muscle tone by adipose-derived contracting factor","volume":"8","author":"Meyer","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.steroids.2024.109423_b0755","doi-asserted-by":"crossref","first-page":"7564","DOI":"10.1038\/srep07564","article-title":"G protein-coupled estrogen receptor protects from atherosclerosis","volume":"4","author":"Meyer","year":"2014","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.steroids.2024.109423_b0760","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1093\/cvr\/cvp187","article-title":"ER\u03b1, ER\u03b2, and gpER: novel aspects of oestrogen receptor signalling in atherosclerosis","volume":"83","author":"Meyer","year":"2009","journal-title":"Cardiovasc. Res."},{"issue":"6","key":"10.1016\/j.steroids.2024.109423_b0765","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1161\/ATVBAHA.117.309054","article-title":"Estrogen receptor control of atherosclerotic calcification and smooth muscle cell osteogenic differentiation","volume":"37","author":"McRobb","year":"2017","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"7","key":"10.1016\/j.steroids.2024.109423_b0770","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1210\/jc.2005-2672","article-title":"Intimal estrogen receptor (ER) \u03b2, but not ER\u03b1 expression, is correlated with coronary calcification and atherosclerosis in pre- and postmenopausal women","volume":"91","author":"Christian","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10","key":"10.1016\/j.steroids.2024.109423_b0775","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1161\/ATVBAHA.118.310792","article-title":"Estrogen inhibits LDL (low-density lipoprotein) transcytosis by human coronary artery endothelial cells via GPER (G-protein-coupled estrogen receptor) and SR-BI (scavenger receptor class B type 1)","volume":"38","author":"Ghaffari","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"2","key":"10.1016\/j.steroids.2024.109423_b0780","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1189\/jlb.3A0914-430RR","article-title":"Estrogen anti-inflammatory activity on human monocytes is mediated through cross-talk between estrogen receptor ER\u03b136 and GPR30\/GPER1","volume":"99","author":"Pelekanou","year":"2016","journal-title":"J. Leukoc. Biol."},{"issue":"7","key":"10.1016\/j.steroids.2024.109423_b0785","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s001090050241","article-title":"Ligand-independent activation of steroid hormone receptors","volume":"76","author":"Weigel","year":"1998","journal-title":"J. Mol. Med. (Berlin)"},{"issue":"2","key":"10.1016\/j.steroids.2024.109423_b0790","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.tips.2005.12.007","article-title":"Recent developments in constitutive receptor activity and inverse agonism, and their potential for GPCR drug discovery","volume":"27","author":"Bond","year":"2006","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.steroids.2024.109423_b0795","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aag0240","article-title":"Obligatory role for GPER in cardiovascular aging and disease","volume":"9","author":"Meyer","year":"2016","journal-title":"Sci. Signal."},{"key":"10.1016\/j.steroids.2024.109423_b0800","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jsbmb.2017.03.019","article-title":"GPER blockers as Nox downregulators: a new drug class to target chronic non-communicable diseases","volume":"176","author":"Meyer","year":"2018","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.steroids.2024.109423_b0805","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.mce.2016.11.019","article-title":"Unliganded estrogen receptor alpha regulates vascular cell function and gene expression","volume":"442","author":"Lu","year":"2017","journal-title":"Mol. Cell. Endocrinol."},{"issue":"13","key":"10.1016\/j.steroids.2024.109423_b0810","doi-asserted-by":"crossref","first-page":"6120","DOI":"10.1073\/pnas.90.13.6120","article-title":"Modulation of the ligand-independent activation of the human estrogen receptor by hormone and antihormone","volume":"90","author":"Smith","year":"1993","journal-title":"PNAS"},{"issue":"6","key":"10.1016\/j.steroids.2024.109423_b0815","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1161\/HYPERTENSIONAHA.111.173427","article-title":"Estrogen-independent activation of estrogen receptors","volume":"57","author":"Barton","year":"2011","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.steroids.2024.109423_b0820","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1161\/HYPERTENSIONAHA.110.167650","article-title":"Activation of estrogen receptor-\u03b1 and of angiotensin-converting enzyme 2 suppresses ischemic brain damage in oophorectomized rats","volume":"57","author":"Shimada","year":"2011","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.steroids.2024.109423_b0825","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1152\/japplphysiol.00382.2023","article-title":"Angiotensin II type 2 receptor-mediated dilation is greater in the cutaneous microvasculature of premenopausal women compared with men","volume":"135","author":"Schwartz","year":"1985","journal-title":"J. Appl. Physiol."},{"issue":"12","key":"10.1016\/j.steroids.2024.109423_b0830","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/j.hlc.2023.09.008","article-title":"Sex differences in pharmacotherapy and long-term outcomes in patients with ischaemic heart disease and comorbid left ventricular dysfunction","volume":"32","author":"Dagan","year":"2023","journal-title":"Heart Lung Circ"},{"issue":"14","key":"10.1016\/j.steroids.2024.109423_b0835","doi-asserted-by":"crossref","first-page":"e028865","DOI":"10.1161\/JAHA.122.028865","article-title":"Sex differences in the effectiveness of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and sacubitril-valsartan for the treatment of heart failure","volume":"12","author":"Sohani","year":"2023","journal-title":"J. Am. Heart Assoc."},{"issue":"2","key":"10.1016\/j.steroids.2024.109423_b0840","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1124\/pharmrev.120.000206","article-title":"Sex- and gender-based pharmacological response to drugs","volume":"73","author":"Mauvais-Jarvis","year":"2021","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.steroids.2024.109423_b0845","doi-asserted-by":"crossref","DOI":"10.1016\/j.vph.2023.107209","article-title":"The impacts of endogenous progesterone and exogenous progestin on vascular endothelial cell, and smooth muscle cell function: a narrative review","volume":"152","author":"Stone","year":"2023","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.steroids.2024.109423_b0850","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0024-3205(01)01174-2","article-title":"Progesterone and 17 \u03b2-estradiol acutely stimulate nitric oxide synthase activity in rat aorta and inhibit platelet aggregation","volume":"69","author":"Selles","year":"2001","journal-title":"Life Sci."},{"key":"10.1016\/j.steroids.2024.109423_b0855","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1161\/01.RES.0000188212.57180.55","article-title":"Progesterone antagonizes the vasoprotective effect of estrogen on antioxidant enzyme expression and function","volume":"97","author":"Wassmann","year":"2005","journal-title":"Circ. Res."},{"key":"10.1016\/j.steroids.2024.109423_b0860","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jss.2004.09.003","article-title":"Effects of progesterone and estrogen on endothelial dysfunction in porcine coronary arteries","volume":"124","author":"Cox","year":"2005","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.steroids.2024.109423_b0865","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1161\/01.ATV.15.7.827","article-title":"Regression of atherosclerosis in female monkeys","volume":"15","author":"Williams","year":"1995","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"8","key":"10.1016\/j.steroids.2024.109423_b0870","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1038\/sj.bjp.0703524","article-title":"The progestin levonorgestrel induces endothelium-independent relaxation of rabbit jugular vein via inhibition of calcium entry and protein kinase C: role of cyclic AMP","volume":"130","author":"Herkert","year":"2000","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.steroids.2024.109423_b0875","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1089\/jwh.2020.8743","article-title":"Prior oral contraceptive use and longer term mortality outcomes in women with suspected ischemic heart disease","volume":"30","author":"Barsky","year":"2021","journal-title":"J Womens Health (Larchmt)"},{"issue":"16","key":"10.1016\/j.steroids.2024.109423_b0880","doi-asserted-by":"crossref","first-page":"e030105","DOI":"10.1161\/JAHA.123.030105","article-title":"Associations of oral contraceptive use with cardiovascular disease and all-cause death: evidence from the UK Biobank Cohort Study","volume":"12","author":"Dou","year":"2023","journal-title":"J. Am. Heart Assoc."},{"issue":"3","key":"10.1016\/j.steroids.2024.109423_b0885","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jacc.2008.09.042","article-title":"Contraceptive hormone use and cardiovascular disease","volume":"53","author":"Shufelt","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.steroids.2024.109423_b0890","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1073\/pnas.86.1.327","article-title":"Characterization and expression of a cDNA encoding the human androgen receptor","volume":"86","author":"Tilley","year":"1989","journal-title":"PNAS"},{"key":"10.1016\/j.steroids.2024.109423_b0895","first-page":"H1569","article-title":"Sex differences in endothelial function important to vascular health and overall cardiovascular disease risk across the lifespan","volume":"315","author":"Stanhewicz","year":"2018","journal-title":"Am. J. Phys. Heart Circ. Phys."},{"key":"10.1016\/j.steroids.2024.109423_b0900","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1210\/endrev\/bnab041","article-title":"Membrane-initiated estrogen, androgen, and progesterone receptor signaling in health and disease","volume":"43","author":"Mauvais-Jarvis","year":"2022","journal-title":"Endocr. Rev."},{"issue":"4","key":"10.1016\/j.steroids.2024.109423_b0905","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1210\/en.2009-1048","article-title":"Androgen receptor-dependent activation of endothelial nitric oxide synthase in vascular endothelial cells: role of phosphatidylinositol 3-kinase\/Akt pathway","volume":"151","author":"Yu","year":"2010","journal-title":"Endocrinology"},{"issue":"5","key":"10.1016\/j.steroids.2024.109423_b0910","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0039-128X(01)00192-1","article-title":"Testosterone inhibits bradykinin-induced intracellular calcium kinetics in rat aortic endothelial cells in culture","volume":"67","author":"Rubio-Gayosso","year":"2002","journal-title":"Steroids"},{"issue":"4","key":"10.1016\/j.steroids.2024.109423_b0915","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/en.2003-0789","article-title":"Dihydrotestosterone promotes vascular cell adhesion molecule-1 expression in male human endothelial cells via a nuclear factor-\u03baB-dependent pathway","volume":"145","author":"Death","year":"2004","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.steroids.2024.109423_b0920","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1139\/O07-011","article-title":"Physiological testosterone stimulates tissue plasminogen activator and tissue factor pathway inhibitor and inhibits plasminogen activator inhibitor type 1 release in endothelial cells","volume":"85","author":"Jin","year":"2007","journal-title":"Biochem. Cell Biol."},{"issue":"4","key":"10.1016\/j.steroids.2024.109423_b0925","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1081\/ERC-200043956","article-title":"Dehydroepiandrosterone sulphate (DHEAS) inhibits growth of human vascular endothelial cells","volume":"30","author":"Hinson","year":"2004","journal-title":"Endocr. Res."},{"issue":"6","key":"10.1016\/j.steroids.2024.109423_b0930","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1161\/HYPERTENSIONAHA.111.180620","article-title":"Testosterone induces vascular smooth muscle cell migration by NADPH oxidase and c-Src-dependent pathways","volume":"59","author":"Chignalia","year":"2012","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.steroids.2024.109423_b0935","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1161\/HYPERTENSIONAHA.112.195149","article-title":"Testosterone and secondary hypertension: new pieces to the puzzle","volume":"59","author":"Barton","year":"2012","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.steroids.2024.109423_b0940","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1073\/pnas.051003698","article-title":"Testosterone inhibits early atherogenesis by conversion to estradiol: critical role of aromatase","volume":"98","author":"Nathan","year":"2001","journal-title":"PNAS"},{"issue":"12","key":"10.1016\/j.steroids.2024.109423_b0945","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1001\/jamaoncol.2016.0429","article-title":"Cardiovascular disease after aromatase inhibitor use","volume":"2","author":"Haque","year":"2016","journal-title":"JAMA Oncol."},{"issue":"7","key":"10.1016\/j.steroids.2024.109423_b0950","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1161\/CIRCULATIONAHA.119.044750","article-title":"Aromatase inhibitors and the risk of cardiovascular outcomes in women with breast cancer: a population-based cohort study","volume":"141","author":"Khosrow-Khavar","year":"2020","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.steroids.2024.109423_b0955","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1161\/ATVBAHA.106.130260","article-title":"Hormone replacement therapy and atherosclerosis in postmenopausal women: does aging limit therapeutic benefits?","volume":"27","author":"Barton","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"7","key":"10.1016\/j.steroids.2024.109423_b0960","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1161\/CIRCULATIONAHA.122.061559","article-title":"ACC CVD in Women Committee. Rethinking menopausal hormone therapy: for whom, what, when, and how long?","volume":"147","author":"Cho","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.steroids.2024.109423_b0965","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1001\/jama.291.14.1701","article-title":"Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women\u2019s Health Initiative randomized controlled trial","volume":"291","author":"Anderson","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.steroids.2024.109423_b0970","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1001\/jama.292.13.1581","article-title":"Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis","volume":"292","author":"Smith","year":"2004","journal-title":"J. Am. Med. Assoc."},{"issue":"3","key":"10.1016\/j.steroids.2024.109423_b0975","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jacc.2022.05.016","article-title":"Contributions of the Women\u2019s Health Initiative to cardiovascular research: JACC State-of-the-Art review","volume":"80","author":"LaMonte","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.steroids.2024.109423_b0980","doi-asserted-by":"crossref","first-page":"e6409","DOI":"10.1136\/bmj.e6409","article-title":"Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial","volume":"345","author":"Schierbeck","year":"2012","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.steroids.2024.109423_b0985","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/clc.22891","article-title":"What the Women's Health Initiative has taught us about menopausal hormone therapy","volume":"41","author":"Chester","year":"2018","journal-title":"Clin. Cardiol."},{"issue":"11","key":"10.1016\/j.steroids.2024.109423_b0990","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1097\/GME.0000000000001228","article-title":"Estrogen effects on arteries vary with stage of reproductive life and extent of subclinical atherosclerosis progression","volume":"25","author":"Clarkson","year":"2018","journal-title":"Menopause"},{"issue":"6","key":"10.1016\/j.steroids.2024.109423_b0995","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1210\/endrev\/bnab011","article-title":"Hormone therapy in menopause: concepts, controversies, and approach to treatment","volume":"42","author":"Flores","year":"2021","journal-title":"Endocr. Rev."},{"issue":"25","key":"10.1016\/j.steroids.2024.109423_b1000","doi-asserted-by":"crossref","first-page":"e506","DOI":"10.1161\/CIR.0000000000000912","volume":"142","author":"El Khoudary","year":"2020","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.steroids.2024.109423_b1005","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1161\/ATVBAHA.108.182279","article-title":"Estrogen and mechanisms of vascular protection","volume":"29","author":"Xing","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.steroids.2024.109423_b1010","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1080\/13697137.2023.2282690","article-title":"Menopausal hormone therapy and coronary heart disease: the roller-coaster history","volume":"27","author":"Nudy","year":"2023","journal-title":"Climacteric"},{"issue":"13","key":"10.1016\/j.steroids.2024.109423_b1015","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMoa1505241","article-title":"Vascular effects of early versus late postmenopausal treatment with estradiol","volume":"374","author":"Hodis","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.steroids.2024.109423_b1020","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s11357-021-00331-3","article-title":"Alterations in the estrogen receptor profile of cardiovascular tissues during aging","volume":"43","author":"Gurrala","year":"2021","journal-title":"Geroscience"},{"issue":"7","key":"10.1016\/j.steroids.2024.109423_b1025","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1161\/ATVBAHA.114.303629","article-title":"Estrogen effects on vascular inflammation are age dependent: role of estrogen receptors","volume":"34","author":"Bowling","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.steroids.2024.109423_b1030","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.tem.2015.02.003","article-title":"Emerging roles of GPER in diabetes and atherosclerosis","volume":"26","author":"Barton","year":"2015","journal-title":"Trends Endocrinol Metab"},{"issue":"6800","key":"10.1016\/j.steroids.2024.109423_b1035","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1136\/bmj.303.6800.435","article-title":"Fatal myocardial infarction in the Scottish adjuvant tamoxifen trial \u2013 the Scottish Breast Cancer Committee","volume":"303","author":"McDonald","year":"1991","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.steroids.2024.109423_b1040","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1200\/JCO.1996.14.2.429","article-title":"Antiatherogenic effects of adjuvant antiestrogens: a randomized trial comparing the effects of tamoxifen and toremifene on plasma lipid levels in postmenopausal women with node-positive breast cancer","volume":"14","author":"Saarto","year":"1996","journal-title":"J. Clin. Oncol."},{"issue":"17","key":"10.1016\/j.steroids.2024.109423_b1045","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1093\/jnci\/85.17.1398","article-title":"Cardiac and thromboembolic morbidity among postmenopausal women with early-stage breast cancer in a randomized trial of adjuvant tamoxifen. The Stockholm Breast Cancer Study Group","volume":"85","author":"Rutqvist","year":"1993","journal-title":"J. Natl Cancer Inst."},{"issue":"11","key":"10.1016\/j.steroids.2024.109423_b1050","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1093\/jnci\/89.11.776","article-title":"Coronary heart disease mortality and adjuvant tamoxifen therapy","volume":"89","author":"Costantino","year":"1997","journal-title":"J. Natl Cancer Inst."},{"issue":"11","key":"10.1016\/j.steroids.2024.109423_b1055","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1046\/j.1525-1497.2003.20724.x","article-title":"Meta-analysis of vascular and neoplastic events associated with tamoxifen","volume":"18","author":"Braithwaite","year":"2003","journal-title":"J. Gen. Intern. Med."},{"issue":"19","key":"10.1016\/j.steroids.2024.109423_b1060","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1161\/CIRCULATIONAHA.104.531178","article-title":"Tamoxifen for the prevention of myocardial infarction in humans: preclinical and early clinical evidence","volume":"112","author":"Grainger","year":"2005","journal-title":"Circulation"},{"issue":"22","key":"10.1016\/j.steroids.2024.109423_b1065","doi-asserted-by":"crossref","first-page":"4201","DOI":"10.1111\/bph.14020","article-title":"Rapid vasodilation to raloxifene: role of oestrogen receptors and off-target effects","volume":"174","author":"Barton","year":"2017","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.steroids.2024.109423_b1070","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1124\/jpet.106.106062","article-title":"Raloxifene elicits combined rapid vasorelaxation and long-term anti-inflammatory actions in rat aorta","volume":"319","author":"Pinna","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.steroids.2024.109423_b1075","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105512","article-title":"Raloxifene has favorable effects on the lipid profile in women explaining its beneficial effect on cardiovascular risk: a meta-analysis of randomized controlled trials","volume":"166","author":"Yang","year":"2021","journal-title":"Pharmacol. Res."},{"issue":"7","key":"10.1016\/j.steroids.2024.109423_b1080","doi-asserted-by":"crossref","first-page":"674","DOI":"10.3109\/09513590.2013.788628","article-title":"Raloxifene modifies the insulin sensitivity and lipid profile of postmenopausal insulin resistant women","volume":"29","author":"Grover-P\u00e1ez","year":"2013","journal-title":"Gynecol. Endocrinol."},{"issue":"7","key":"10.1016\/j.steroids.2024.109423_b1085","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.recesp.2011.03.005","article-title":"Efecto del raloxifeno en la funci\u00f3n endotelial y la hemostasia en mujeres con enfermedad coronaria [Effects of raloxifene on endothelial function and hemostasis in women with ischemic heart disease]","volume":"64","author":"Roqu\u00e9","year":"2011","journal-title":"Rev. Esp. Cardiol."},{"issue":"17","key":"10.1016\/j.steroids.2024.109423_b1090","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1161\/CIRCULATIONAHA.109.924571","article-title":"Lasofoxifene and cardiovascular events in postmenopausal women with osteoporosis: five-year results from the Postmenopausal Evaluation and Risk Reduction with Lasofoxifene (PEARL) trial","volume":"122","author":"Ensrud","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.steroids.2024.109423_b1095","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa062462","article-title":"Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women","volume":"355","author":"Barrett-Connor","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.steroids.2024.109423_b1100","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1161\/CIRCULATIONAHA.108.817577","article-title":"Effects of the selective estrogen receptor modulator raloxifene on coronary outcomes in the Raloxifene Use for The Heart trial: results of subgroup analyses by age and other factors","volume":"119","author":"Collins","year":"2009","journal-title":"Circulation"},{"issue":"23","key":"10.1016\/j.steroids.2024.109423_b1105","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1161\/01.CIR.0000018121.67607.CE","article-title":"Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Obesity accelerates the progression of coronary atherosclerosis in young men","volume":"105","author":"McGill","year":"2002","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.steroids.2024.109423_b1110","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.repc.2017.08.008","article-title":"Cardiovascular risk in Turner syndrome","volume":"37","author":"Donato","year":"2018","journal-title":"Rev Port Cardiol (engl Ed)"},{"issue":"8","key":"10.1016\/j.steroids.2024.109423_b1115","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1038\/s41591-022-01891-3","article-title":"Large-scale genome-wide association study of coronary artery disease in genetically diverse populations","volume":"28","author":"Tcheandjieu","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.steroids.2024.109423_b1120","doi-asserted-by":"crossref","first-page":"e78263","DOI":"10.7554\/eLife.78263","article-title":"Age acquired skewed X chromosome inactivation is associated with adverse health outcomes in humans","volume":"11","author":"Roberts","year":"2022","journal-title":"eLife"},{"issue":"1","key":"10.1016\/j.steroids.2024.109423_b1125","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13293-023-00527-6","article-title":"X chromosome inactivation skewing is common in advanced carotid atherosclerotic lesions in females and predicts secondary peripheral artery events","volume":"14","author":"Buono","year":"2023","journal-title":"Biol. Sex Differ."},{"issue":"14","key":"10.1016\/j.steroids.2024.109423_b1130","doi-asserted-by":"crossref","first-page":"4812","DOI":"10.3390\/jcm12144812","article-title":"Chromosome Y haplogroup R was associated with the risk of premature myocardial infarction with ST-elevation: data from the CholeSTEMI registry","volume":"12","author":"Lorca","year":"2023","journal-title":"J. Clin. Med."},{"issue":"12","key":"10.1016\/j.steroids.2024.109423_b1135","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.3390\/ijms20122892","article-title":"Y chromosome, hypertension and cardiovascular disease: is inflammation the answer?","volume":"20","author":"Khan","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.steroids.2024.109423_b1140","doi-asserted-by":"crossref","first-page":"e001544","DOI":"10.1161\/CIRCGENETICS.116.001544","article-title":"Loss of Y chromosome in blood is associated with major cardiovascular events during follow-up in men after carotid endarterectomy","volume":"10","author":"Haitjema","year":"2017","journal-title":"Circ. Cardiovasc. Genet."},{"issue":"10250","key":"10.1016\/j.steroids.2024.109423_b1145","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(20)31561-0","article-title":"Sex and gender: modifiers of health, disease, and medicine","volume":"396","author":"Mauvais-Jarvis","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.steroids.2024.109423_bib1171","doi-asserted-by":"crossref","first-page":"eabm2090","DOI":"10.1126\/scitranslmed.abm2090","article-title":"Sex differences in kidney metabolism may reflect sex-dependent outcomes in human diabetic kidney disease","volume":"16","author":"Clotet-Freixas","year":"2024","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.steroids.2024.109423_bib1172","doi-asserted-by":"crossref","unstructured":"C. Greenhill, Sex differences in diabetic kidney disease explained. Nat Rev Endocrinol. 2024 Mar 20. Epub ahead of print. https:\/\/doi.org\/10.1038\/s41574-024-00982-0. https:\/\/www.nature.com\/articles\/s41574-024-00982-0.","DOI":"10.1038\/s41574-024-00982-0"},{"key":"10.1016\/j.steroids.2024.109423_b1150","doi-asserted-by":"crossref","DOI":"10.1016\/j.steroids.2019.108494","article-title":"Nox1 downregulators: a new class of therapeutics","volume":"152","author":"Barton","year":"2019","journal-title":"Steroids"},{"issue":"10","key":"10.1016\/j.steroids.2024.109423_b1155","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1161\/01.ATV.0000242186.93243.25","article-title":"Selective agonists of estrogen receptor isoforms: new perspectives for cardiovascular disease","volume":"26","author":"Bolego","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"7","key":"10.1016\/j.steroids.2024.109423_b1160","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1096\/fj.09-139220","article-title":"Selective estrogen receptor-\u03b1 agonist provides widespread heart and vascular protection with enhanced endothelial progenitor cell mobilization in the absence of uterotrophic action","volume":"24","author":"Bolego","year":"2010","journal-title":"FASEB J."},{"issue":"12","key":"10.1016\/j.steroids.2024.109423_b1165","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1016\/j.chembiol.2019.10.009","article-title":"A selective ligand for estrogen receptor proteins discriminates rapid and genomic signaling","volume":"26","author":"Revankar","year":"2019","journal-title":"Cell Chem. Biol."},{"issue":"528","key":"10.1016\/j.steroids.2024.109423_b1170","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aau5956","article-title":"Preclinical efficacy of the GPER-selective agonist G-1 in mouse models of obesity and diabetes","volume":"12","author":"Sharma","year":"2020","journal-title":"Sci. Transl. Med."}],"container-title":["Steroids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X24000618?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X24000618?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T12:55:35Z","timestamp":1715172935000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039128X24000618"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":236,"alternative-id":["S0039128X24000618"],"URL":"https:\/\/doi.org\/10.1016\/j.steroids.2024.109423","relation":{},"ISSN":["0039-128X"],"issn-type":[{"value":"0039-128X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sex and sex steroids as determinants of cardiovascular risk","name":"articletitle","label":"Article Title"},{"value":"Steroids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.steroids.2024.109423","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109423"}}